2 Stocks Hitting Low Notes
By
Motley Fool Staff
February 19, 2009
|
When a stock hits a fresh low, it can either signal a dirt cheap dream stock or a dreadful stock to avoid. Separating the wheat from the chaff is difficult, but finding well-run companies at bargain-basement prices is a great way to accumulate a fortune over the long run.
With that in mind, we'll use the aggregate intelligence of the 125,000-plus investors participating in Motley Fool CAPS to see what the community is saying about stocks hitting 52-week lows today. The community's approval (signified by four- and five-star ratings) could indicate that further research is in order.
Here are two such stocks:
| Company |
Today’s Intraday Price
|
Industry
|
CAPS Rating (out of 5)
|
Fools Saying Outperform
|
|
BioMarin Pharmaceutical, Inc. (Nasdaq: BMRN)
|
$12.31
|
Biotechnology
|
|
868 of 911
|
|
National Instruments Corp (Nasdaq: NATI)
|
$18.48
|
Electronic Equipment, Instruments and Components
|
|
315 of 331
|
Source: Motley Fool CAPS, as of Feb. 19, 2009.
Top-rated biotechnology companies:
-
Momenta Pharmaceuticals, Inc. (Nasdaq: MNTA): Stock price is 41% higher than last year.
-
Cephalon, Inc. (Nasdaq: CEPH): Stock price is 22% higher than last year.
Top-rated chemicals companies:
-
Sociedad Quimica y Minera (ADR) (NYSE: SQM): Stock price is 75% higher than last year.
-
Balchem Corp (Nasdaq: BCPC): Stock price is 1% higher than last year.
Join us on CAPS to learn more about these and countless other interesting stock ideas.
“The Next Great Investment”… That’s how a top global investor describes India’s potential. On Nov. 28, The Motley Fool’s Tim Hanson returns to India to prove it. Follow along in real time and get his TOP pick first (Hanson returned from China in July with a stock that’s up 169%!). Enter email below.
Terms & Conditions
RSS Headlines
Fool UK